Clinical TrialsSearch results
Number of results: 614
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Recruiting
- A multiple-ascending dose study of RO7126209 in patients with prodromal or mild to moderate Alzheimer's disease
- Alzheimer's disease
- Luka Kulic MD
- 2023-09-12
Recruiting
- A Study to Compare Darolutamide Given With Androgen Deprivation Therapy (ADT) With ADT in Men With Nonmetastatic Prostate Cancer and Raise of Prostate Specific Antigen (PSA) Levels After Local Therapies
- prostate cancer
- Tanigawa Takahiko
- 2023-09-04
Recruiting
- Double-blind, randomized, controlled trial of EIM-001 for in patients with Fontaine classification 3 and 4 lower extremity atherosclerosis obliterans
- atherosclerosis obliterans
- Kato Takao
- 2023-08-25
Not yet recruiting
- Kyoto Cancer Pain Nerve Block Cooperation
- intractable cancer pain
- Amaya Fumimasa
- 2023-08-18
Recruiting
- Clinical trial to evaluate the safety and feasibility of online adaptive radiotherapy using cone-beam CT for pancreatic cancer
- pancreatic cancer
- Mizowaki Takashi
- 2023-08-18
Recruiting
- A Phase II stUdy to evaluate the efficacy and safety of deep-inspiration breath-hold Daily aDaptive radiotherapy In ceNtrally located lunG tumors
- Primary lung tumor; Lung cancer; Metastatic lung tumor; Pulmonary metastasis; Oligometastasis
- Takashi Mizowaki
- 2023-08-12
Recruiting
- AF app study
- Atrial fibrillation
- Senoo Keitaro
- 2023-07-26
Recruiting
- Pembrolizumab and EV With Radiation Therapy for MIBC Patients
- Muscle invasive bladder cancer
- Kobayashi Takashi
- 2023-07-20
Recruiting
- A Phase 1 Study of Lomustine and PCV in Japanese Patients with Glioma
- Glioma
- ARAKAWA Yoshiki
- 2023-07-19
Recruiting
- Sodium zirconium cyclosilicate non-Inferiority on hyperkalemia (Level of serum potassium) VErsus potassium Restricted diet in Subjects with type 2 diabetes mellitus; multicenter, open-label, randomized controlled, Two-Arm Research
- type 2 diabetes mellitus, hyperkalemia
- Hamaguchi Masahide
- 2023-07-11